Cargando…
Synthesis and In Vitro Testing of YVO(4):Eu(3+)@silica-NH-GDA-IgG Bio-Nano Complexes for Labelling MCF-7 Breast Cancer Cells
We present a visual tool and facile method to detect MCF-7 breast cancer cells by using YVO(4):Eu(3+)@silica-NH-GDA-IgG bio-nanocomplexes. To obtain these complexes, YVO(4):Eu(3+) nanoparticles with a uniform size of 10–25 nm have been prepared firstly by the hydrothermal process, followed by surfac...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822125/ https://www.ncbi.nlm.nih.gov/pubmed/36615474 http://dx.doi.org/10.3390/molecules28010280 |
Sumario: | We present a visual tool and facile method to detect MCF-7 breast cancer cells by using YVO(4):Eu(3+)@silica-NH-GDA-IgG bio-nanocomplexes. To obtain these complexes, YVO(4):Eu(3+) nanoparticles with a uniform size of 10–25 nm have been prepared firstly by the hydrothermal process, followed by surface functionalization to be bio-compatible and conjugated with cancer cells. The YVO(4):Eu(3+)@silica-NH-GDA-IgG nanoparticles exhibited an enhanced red emission at 618 nm under an excitation wavelength of 355 nm and were strongly coupled with MCF-7 breast cancer cells via biological conjugation. These bio-nanocomplexes showed a superior sensitiveness for MCF-7 cancer cell labelling with a detection percentage as high as 82%, while no HEK-293A healthy cells were probed under the same conditions of in vitro experiments. In addition, the detection percentage of MCF-7 breast cancer cells increased significantly via the functionalization and conjugation of YVO(4):Eu(3+) nanoparticles. The experimental results demonstrated that the YVO(4):Eu(3+)@silica-NH-GDA-IgG bio-nanocomplexes can be used as a promising labelling agent for biomedical imaging and diagnostics. |
---|